Introduction
Glucocorticoids (GC) play an important role in the developmental organization and ongoing activities of the nervous system [1] . At cellular level, they work in a diverse manner. A genomic mechanism where the complex of GC and their receptors acts as nuclear transcription factor has been well elucidated over the past 30 years, and accounts for the long-latency effects of most GC. However, some of their actions take place so rapidly (onset in seconds or minutes) that they do not fit into the paradigm of the genomic mechanism [2, 3] . There are many examples in which GC act through the rapid, non-genomic way in the nervous system, ranging from the regulation of neuronal excitability to the modulation of neurotransmitter secretion and uptake [1, 2] . The HT4 neuroblastoma cell line was derived from the hippocampal neurons of mice [4] . In our previous observations, we found an ATP-induced transient in [Ca 2+ ] i within the cells [5] . The Ca 2+ response was decreased by the activation of protein kinase A (PKA) or protein kinase C (PKC) (unpublished data). As it is already known that some of the rapid actions of GC are mediated by protein kinases [6, 7] , we wonder whether there is a similar signaling pathway for GC in HT4 cells, which may result in fast modification of the ATP-induced Ca 2+ response. We provide evidence showing that ATP-induced Ca 2+ response can be rapidly modified by GC through a membrane-initiated, nongenomic pathway that is PKA dependent.
Materials and methods
Materials ATP, β, γ-meATP, bovine serum albumin con- ] i elevation induced by the P2X receptor agonist adenosine 5'-(β,γ-methylene) triphosphate (β,γ-meATP) was also suppressed. The rapid inhibitory effect of B can be reproduced by forskolin 1 mmol/L and blocked by H89 20 mmol/L. Neither nuclear glucocorticoid receptor antagonist mifepristone nor protein kinase C inhibitors influenced the rapid action of B. Conclusion: Our results suggest that glucocorticoids modulate P2X receptor-medicated Ca 2+ influx through a membrane-initiated, non-genomic and PKA-dependent pathway in HT4 cells. 2+ ] i . The cells on the coverslips were loaded in situ at 37 ºC for 30-60 min in HEPES-buffered saline (in mmol/L: NaCl 140, KCl 5, MgCl 2 1, CaCl 2 2.5, glucose 11.5, HEPES 10, pH 7.2-7.4) containing Fura-2 AM 2 µmol/L and 0.04% pluronic F-127. The Fura-2-loaded cells were then rinsed three times with saline and mounted in a perfusion chamber for immediate [Ca 2+ ] i measurements. Alternatively, they were kept in dark conditions at room temperature for up to 2 h. Fura-2 loading was uniform over the cytoplasm, and compartmentalization of the dye was seldom observed.
[ ] i was carried out by the dual-wavelength fluorescence method as described previously [8] with some modifications. Fura-2-loaded cells were mounted in a perfusion chamber and placed under an inverted microscope (IX70, Olympus). Light emitted from a 75-Wxenon arc lamp (AH2-RX, Olympus) passed through an excitation filter set (Chroma) to generate ultraviolet monochromatic waves of 340 and 380 nm. With the aid of a computerized filter wheel (Lambda 10-2, Sutter Instruments), the cells in the chamber were alternately exposed to the two waves through an Olympus objective (UApo/340, 40× /0.90). The resulting fluorescent emission from the Ca 2+ -sensitive dye was collected through a 510 nmlong pass filter (Chroma) with a cooled charge-coupled device camera (MicroMax 5 MHz system, Princeton Instruments). All image acquisition was computer-controlled by [8] , where R max and R min are the maximum and minimum ratio obtained by the addition of ionomycin (10 µmol/L) and egtazic acid (10 mmol/L) respectively, F Perfusion chamber and drug applications The custom-built chamber, with a coverglass at the bottom, was continuously perfused with HEPES-buffered saline during measurements. The perfusion rate was set at 2 mL/min to aid drug removal. All drugs were diluted in saline from their stock solutions immediately before the experiments and applied directly to the cells using a computer/manual operated 7-barrel local superfusion system for desired lengths of time. The tip (100 µm inside diameter) of the outlet was placed approximately 200 µm away from the cells, and the gravity force was adjusted to achieve rapid drug application while avoiding any mechanical disturbance of the cells. The time delay for arrival of drugs at the cells was less than 100 ms (data not shown).
Data analysis [Ca 2+ ] i values were expressed as means± SD. Statistical analysis was performed using t-test or analysis of variance (ANOVA) depending on data types. P<0.05 was considered to be significant.
Results

Inhibition of ATP-induced [Ca
2+
] i increase by GCs In HT 4 cells, the basal level of [Ca 2+ ] i was 54±8 nmol/L [5] . ATP 100 µmol/L induced an immediate rise in [Ca 2+ ] i , which was significantly attenuated by pre-incubation with B (1 µmol/L) for 5 min ( Figure 1A) . The original Ca 2+ response recovered 5-10 min after B was washed out (data not shown). The inhibitory effect was concentration-dependent (0.1-100 µmol/L). B-BSA was also effective in suppressing the Ca 2+ response with a similar potency compared to B (Figure 1B) , while BSA had no effect on either basal or stimulated [Ca 2+ ] i levels (data not shown). To further elucidate the rapid action of B, we studied the effect of mifepristone (a GR antagonist) on the response. Pretreatment with mifepristone (1 µmol/L) for 30 min did not influence the inhibitory effect of B (1 µmol/L) (data not shown). Thus, the findings above imply that the action of B in HT4 cells is initiated at the plasma membrane and may not involve the nuclear receptors.
Other GCs or analogs, such as cortisol and dexamethasone, were also tested and shown to be effective using the same experimental protocol. However, deoxycorticosterone and cholesterol were not effective ( Figure 1C) ] i level dropped gradually to baseline even if ATP was not withdrawn. The subsequent introduction from the local superfusion system of 2.5 mmol/L Ca 2+ -containing ATP solution to the same cells gave rise to a secondary calcium elevation (Figure 2A) . These results suggest the generation of both Ca 2+ influx across plasma membrane and Ca 2+ release from intracellular stores upon ATP treatment. Using this experimental protocol, we investigated which component of the Ca 2+ response was affected by the brief treatment of B. As shown in Figure 2A , the Ca 2+ release evoked by ATP was not affected while the [Ca 2+ ] i increment during Ca 2+ influx was significantly smaller after the pre-incubation of B (1 µmol/L). β,γ-meATP is a specific agonist for P2X receptors that has little effect on P2Y receptors [9] . The [Ca 2+ ] i increase induced by β,γ-meATP 10 µmol/L in HT4 cells was also inhibited by the pre-incubation of B (1 µmol/L) ( Figure  2B and 2C). Taken together, the above results suggest that Ca 2+ influx through P2X receptors was affected by B. Effect of B on Ca 2+ influx through SOC As shown earlier, ATP increases Ca 2+ release from intracellular stores in HT4 cells. The depletion of the Ca 2+ stores has been reported to trigger the opening of store-operated channels (SOC) [10, 11] . We therefore examined whether B might exert its inhibitory effect by reducing Ca 2+ influx through SOC. Thapsigargin (TG), a specific inhibitor of endoplasmic reticulum Ca 2+ -ATPase, is widely used to activate SOC by depleting Ca 2+ stores. In HT4 cells, exposure of TG (1 µmol/L) caused an initial spike followed by a sustained elevation at lower level that was indicative of the activation of SOC. Our results showed that the TG-induced plateau was insensitive to treatment of B (1 µmol/L), while ATP-induced further increase in [Ca 2+ ] i at this stage was still attenuated by B (Figure 3 ). Rapid action of B was PKA-dependent Our previous observation found that ATP-induced [Ca 2+ ] i increase was negatively modulated by PKA or PKC in HT-4 cells [5] . Therefore we examined whether PKA or PKC related signaling pathways were involved in the rapid action of B. Effects of forskolin (1 µmol/L), PMA (0.5 µmol/L) on the [Ca 2+ ] i increase were studied and compared with that of B (1 µmol/L). There was no significant difference in the degrees of inhibition among groups pretreated with forskolin or B, or both, while the effect of a combination of PMA and B was addi- 
Discussion
Pre-incubation with B inhibited the ATP-induced [Ca 2+ ] i increase in HT4 cells in a concentration-dependent manner. The minimum effective dose was 100 µmol/L, which falls below the peak-free B concentration (750 µmol/L) in serum during stress [12] . The pre-incubation time for B adopted in most of our experiments was 5 min. However, a 3-min pretreatment was found to be enough for B to take effect (data not shown). The very short latency is consistent with the criteria to define a rapid effect of steroid hormones [1] . Moreover, the rapid action was insensitive to treatment with nuclear receptor antagonist, further supporting the notion that this is a nongenomic effect of B.
Being large and predominantly hydrophilic molecules, steroid-BSA conjugates are thought to be membrane impermeable within 30 min [13] . However, they are biologically active and can reproduce the actions of free steroids [14] . In our study, B-BSA was found to be effective in inhibiting 
ATP-induced [Ca
2+
] i increase, suggesting its action at the plasma membrane, where a signal was generated and transduced into the cells. Untill now, several specific membrane proteins have been reported as the receptors that mediate the rapid actions of GC [15, 16] . It is interesting to note that they are different not only in molecular weight, but also in genetic identity. Being a splice variant of the nuclear GR, one membrane receptor has been reported to have crossantigenicity with its nuclear counterpart, while others do not [17] . The identity of the membrane target in HT4 cells is not clear and needs to be elucidated.
The potency of B-BSA in this experimental model is almost the same as that of B. Previous work in our lab has revealed that both B and B-BSA activate PKC in PC12 cells, but the dose-dependence curve of the latter shifts rightward (ie, with lower potency) [6] . The reason for the difference is also unclear.
ATP, being a normal metabolite, exists in all living cells.
In the nervous system, it is an important signaling molecule belonging to a class of fast excitatory transmitter in the brain [18, 19] . Its signaling is mediated through the metabotropic P2Y and ionotropic P2X receptors [9] . In our experiment, the stable ATP analog β,γ-meATP was shown to be a potent agonist in HT4 cells. This result strongly implies actions at P2X receptors. Modulation of P2X purinoceptor-mediated Ca 2+ responses by protein kinases has been well investigated [10, [20] [21] [22] . In PC12 cells, for example, ATP-induced Ca 2+ influx through P2X receptors is inhibited when PKC activity is enhanced [10] . It has been reported that PKA is involved in the GC rapid, nongenomic actions in many cell models [2] . It is interesting to note that the models are all pituitary-originated, such as rat pituitary cells in culture [23] , cichlid fish pituitary in vitro [24] , and mouse corticotroph tumor cell line AtT20 [25] . In contrast, studies on rat brain synaptosomes, rat hippocampal neurons, PC12 cells, and glial cell lines reveal an alternative PKC pathway [2, 26] . This prompted us to speculate that the protein kinases involved in GC rapid action could be predicted by cell type [2] . However, the present data we found in HT4 cells, a mouse hippocampus-derived cell line, show that such generalization is premature and open to further consideration.
